25.05.2024 12:15:47 - *DJ Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio

(MORE TO FOLLOW) Dow Jones Newswires

May 25, 2024 06:15 ET (10:15 GMT)
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
NOVARTIS NAM. SF 0,49 904278 Hamburg 0,000 26.09.24 16:23:51 ±0,000 ±0,00% 0,000 0,000 0,000 80,190
NOVARTIS NAM. ADR 1 907122 Frankfurt 103,500 26.09.24 13:01:57 +2,000 +1,97% 102,500 104,500 102,500 101,500

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH